Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001806796 | SCV002051246 | likely benign | not specified | 2021-12-18 | criteria provided, single submitter | clinical testing | Variant summary: KIF7 c.2760G>A alters a conserved nucleotide resulting in a synonymous change. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.6e-05 in 247434 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2760G>A in individuals affected with Acrocallosal Syndrome/Joubert Syndrome 12 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. |
Labcorp Genetics |
RCV002074174 | SCV002490430 | likely benign | Acrocallosal syndrome | 2021-06-01 | criteria provided, single submitter | clinical testing |